Oxygen Containing Hetero Ring (e.g., Dioxirane, Etc.) Patents (Class 549/200)
  • Patent number: 5808094
    Abstract: A process for the preparation of mixed crystals of 1,4-diketopyrrolo?3,4-c!pyrroles, consisting of 1 mol each of two different compounds of formula ##STR1## by heating a corresponding mixture in solid form to the temperature range from 220.degree. to 380.degree. C.A and B are, for example, each a group of formula ##STR2## wherein R.sub.1 and R.sub.2 are each independently hydrogen, chloro, bromo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkylamino, phenyl or --CN,G is --O--, --NR.sub.7 --, --N.dbd.N-- or --SO.sub.2 --,R.sub.3 and R.sub.4 are hydrogen, and R.sub.7 is hydrogen, methyl or ethyl.The mixed crystals and solid solutions obtained are excellently suited for pigmenting high molecular weight material.
    Type: Grant
    Filed: July 22, 1997
    Date of Patent: September 15, 1998
    Assignee: Ciba Specialty Chemicals Corporation
    Inventors: Jin Mizuguchi, Zhimin Hao, Olof Wallquist, Abul Iqbal
  • Patent number: 5785887
    Abstract: A peroxygen bleaching composition which comprises approximately by weight a mixture of about 1 to about 75% of an inorganic peroxygen bleaching compound; and about 1 to about 75% peroxygen ketalcycloalkanedione bleachant activator.
    Type: Grant
    Filed: February 20, 1996
    Date of Patent: July 28, 1998
    Assignee: Colgate-Palmolive Company
    Inventors: Robert Steltenkamp, Robert Heffner
  • Patent number: 5780008
    Abstract: The invention relates to polyhydric phenol compounds of the general formula ##STR1## wherein R is a hydrogen atom or a saccharide moiety;A and B are hydrogen atoms or form together a C--C bond;R.sub.1 is a hydroxy group and R.sub.2 is a hydrogen atom, orR.sub.1 and R.sub.2 form together an oxygen atom;Z is a hydroxy group, an amino group, a carboxy group or a N-(carboxymethyl)carbamoyl group;X* is a radioactive halogen isotope; andm and n are 0 or 1, with the proviso, that m is 1 if n is 0, andthat m is 0 if n is 1.The radiolabelled phenol compounds can be used for diagnosis and therapy.
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: July 14, 1998
    Assignee: Mallinckrodt Medical, Inc.
    Inventor: John Janine Rene Mertens
  • Patent number: 5747303
    Abstract: The invention is directed to a novel compound of formula ##STR1## in which R is a hydroxyl, alkyloxy, phenylalkyloxy or --NH--CH.sub.2 --COOH radical, R' and R" are identical and are each a hydroxy or methoxy radical and R'" represents a hydrogen, bromine, chlorine or iodine atom or a nitro radical. The invention is also directed to the salts of said compounds and their use.
    Type: Grant
    Filed: November 19, 1996
    Date of Patent: May 5, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Jacques Debernard, Catherine Dubertret, Gerard Helynck, Jean Leboul, Jean-Paul Martin
  • Patent number: 5739022
    Abstract: A method is provided for nonoxidatively cleaving the phosphorus-oxygen linkage of nucleic acids and certain anticholinesterases such as insecticides using a macrocyclic copper(II) complex. A composition suited for such cleavage is also provided.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: April 14, 1998
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Judith N. Burstyn, Eric L. Hegg, Kim A. Deal
  • Patent number: 5739372
    Abstract: The present invention relates to oxaphosphorins of the formula ##STR1## where Ar-Ar is 1-phenylnaphthyl or 1,1'-binaphthyl, R.sup.1 and R.sup.2 are identical or different and are F, Cl, alkyl or alkoxy each having from I to 8 carbon atoms or substituted or unsubstituted aryl, a and b are identical or different and are each an integer from 0 to 4, or Ar-Ar is biphenyl, R.sup.1 and R.sup.2 are identical or different and are substituted or unsubstituted aryl, a and b are as defined above, but a+b.gtoreq.1, X is Cl or Br and the Ar-P and Ar-O bonds are each arranged in the ortho position to the Ar-Ar bond.The invention further relates to a process for preparing these oxaphosphorins.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: April 14, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Dieter Regnat, Hans-Jerg Kleiner
  • Patent number: 5708178
    Abstract: Novel acceptor-donor-acceptor and donor-acceptor-donor compounds for use in forming a thermally-stable electro-optic waveguide are disclosed. Also disclosed is a thermally stable waveguide material containing thermally stable acceptor-donor-acceptor or donor-acceptor-donor guest dipole compounds in a temperature-resistant polymer matrix. The waveguide has selected regions in which the net dipoles of the guest molecules are oriented, for electro-optic switching when an electric field is placed across these regions.
    Type: Grant
    Filed: September 20, 1996
    Date of Patent: January 13, 1998
    Assignee: Lockheed Martin Corporation
    Inventors: Susan P. Ermer, Doris S. Y. Leung, Steven M. Lovejoy
  • Patent number: 5663368
    Abstract: This invention relates to novel diastereomeric acid addition salts of homochiral hydroxylamines, to processes for obtaining such, to processes for the conversion thereof to the corresponding homochiral hydroxylamines, to certain novel homochiral hydroxylamines and the processes for using these as intermediates.
    Type: Grant
    Filed: April 11, 1996
    Date of Patent: September 2, 1997
    Assignee: Smithkline Beecham Corporation
    Inventors: Joseph R. Flisak, Stephen Torey Ross
  • Patent number: 5652096
    Abstract: Hybridization method for discriminating between complementarity and partial complementarity of DNA base sequences. Kinetic covalent entrapment of PCR-amplified target DNA is achieved through the use of crosslinkable probes. A crosslinking site is introduced into the target DNA via the PCR amplification process. Problems with renaturation of target DNA in the PCR process and in the hybridization reaction are minimized.
    Type: Grant
    Filed: April 20, 1994
    Date of Patent: July 29, 1997
    Assignee: HRI Research Inc.
    Inventor: George D. Cimino
  • Patent number: 5646158
    Abstract: This invention relates to certain 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds which are useful in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).
    Type: Grant
    Filed: February 27, 1996
    Date of Patent: July 8, 1997
    Assignee: SmithKline Beecham Corporation
    Inventors: Siegfried B. Christensen, IV, Joseph M. Karpinski, M. Dominic Ryan, Paul E. Bender
  • Patent number: 5622821
    Abstract: The invention provides lanthanide chelates capable of intense luminescence. The celates comprise a lanthanide chelator covalently joined to a coumarin-like or quinolone-like sensitizer. Exemplary sensitzers include 2- or 4-quinolones, 2- or 4-coumarins, or derivatives thereof e.g. carbostyril 124 (7-amino-4-methyl-2-quinolone), coumarin 120 (7-amino-4-methyl-2-coumarin), coumarin 124 (7-amino-4-(trifluoromethyl)-2-coumarin), aminomethyltrimethylpsoralen, etc.The chelates form high affinity complexes with lanthanides, such as terbium or europium, through chelator groups, such as DTPA. The chelates may be coupled to a wide variety of compounds to create specific labels, probes, diagnostic and/or therapeutic reagents, etc. The chelates find particular use in resonance energy transfer between chelate-lanthanide complexes and another luminescent agent, often a fluorescent non-metal based resonance energy acceptor.
    Type: Grant
    Filed: June 29, 1994
    Date of Patent: April 22, 1997
    Assignee: The Regents of the University of California
    Inventors: Paul R. Selvin, John Hearst
  • Patent number: 5621118
    Abstract: A process for oxidizing a substrate susceptible to nucleophilic oxidation by reacting a bicaroate or monopersulfate solution with the substrate is disclosed. In one aspect, the substrate is introduced into the reaction mixture in an inert carrier gas, which can also serve to sweep the product out of the mixture. In a second aspect the oxidation solution is obtained by a two stage neutralization of a Caro's acid solution, the first stage to e.g. 0.5 to 2.0 and the second stage to about 7 to 9. In preferred embodiments, the substrate is introduced into partially neutralized Caro's acid, and the second stage neutralization in the presence of the substrate is most preferably carried out with an alkali salt such as sodium bicarbonate. The process can employ relatively low ratios of substrate: Caro's acid oxidant and homogeneous reaction conditions. The process is particularly useful for preparing dioxiranes from ketones.
    Type: Grant
    Filed: April 14, 1994
    Date of Patent: April 15, 1997
    Assignee: Solvay Interox Limited
    Inventors: Craig W. Jones, William R. Sanderson, John P. Sankey
  • Patent number: 5453421
    Abstract: Novel compounds useful, for example, for the treatment of ischemic conditions and arrhythmia are disclosed. The compounds have the formula ##STR1## wherein X is oxygen or sulfur and the R groups are as defined herein.
    Type: Grant
    Filed: August 12, 1993
    Date of Patent: September 26, 1995
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Karnail S. Atwal, Syed Z. Ahmed, Dinos P. Santafianos
  • Patent number: 5360915
    Abstract: A modified alkali metal or ammonium huminate being made from molecules of the group consisting of ##STR1## wherein R.sub.1, R.sub.3 and R.sub.4 are individually hydrogen or --OH, R.sub.2 is ##STR2## or --CH.sub.2 -- and R.sub.5 and R.sub.6 are individually selected from the group consisting of hydrogen, --OH and --OCH.sub.3, with the proviso that R.sub.4, R.sub.5 and R.sub.6 are not all hydrogen at the same time and their preparation and their medical uses.
    Type: Grant
    Filed: October 14, 1992
    Date of Patent: November 1, 1994
    Assignee: Rutgerswerke Aktiengesellschaft AG
    Inventors: Urs N. Riede, Bernhard Seubert
  • Patent number: 5334732
    Abstract: A process for oxidizing cephalomannine and related taxanes in the presence of taxol is described. The process involves the use of ozone which is able to oxidize cephalomannine and easily oxidizable taxanes while leaving taxol essentially unchanged. Taxol can then be separated from the oxidized cephalomannine and other oxidized taxanes using conventional procedures. A process for oxidizing taxanes is also provided.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: August 2, 1994
    Assignee: Hauser Chemical Research, Inc.
    Inventors: Christopher K. Murray, Timothy D. Ziebarth, Jeffrey T. Beckvermit
  • Patent number: 5242796
    Abstract: A DNA sequencing system and method are described to detect the presence of radiant energy emitted from different excited reporter dye-labeled species (DNA fragments) following separation in time and/or space, and the identity of the species which emit radiant energy closely spaced in wavelength. Functions of the emitted energy are obtained which vary over the wavelengths of the closely spaced spectra in different senses and the functions ratioed, whereby the ratio is indicative of the identity of the DNA fragments.The emitting portion of the reporter-labeled DNA fragment is preferably one of a family of fluorescent dyes based on 9-carboxyethyl-6-hydroxy-3-oxo-3 H-xanthene. These xanthene dyes are covalently attached to the DNA fragments through the carboxylic acid functionality, preferably via an amide linkage. The dyes may be protected by including an alkoxy group at the 9-position. A spacer may be inserted between the dye and the amine.
    Type: Grant
    Filed: October 22, 1991
    Date of Patent: September 7, 1993
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: James M. Prober, Rudy J. Dam, Charles W. Robertson, Jr, Frank W. Hobbs, Jr., George L. Trainor
  • Patent number: 5136033
    Abstract: Novel fluorogenic ionophores have been synthesized which selectively bind ions such as potassium and sodium, even in neutral aqueous and alcoholic media and respond to such binding by fluorescence quenching or enhancement. These ionophores are ideal for the selective and direct determination of ions in biological or environmental samples and the like. The ionophores are also suitable for incorporation into fiber optic-based sensors for the continuous in vivo or in vitro monitoring of metal ions in blood or other biological fluids.
    Type: Grant
    Filed: August 24, 1987
    Date of Patent: August 4, 1992
    Assignee: Allied-Signal Inc.
    Inventors: Divakaran Masilamani, Mariann E. Lucas, George S. Hammond
  • Patent number: 5132204
    Abstract: A stable 1,2-dioxetane of the formula: ##STR1## wherein X' is a phenyl group with 0 to 2 Cl or I atoms. This 1,2-dioxetane is a double-trigger substrate. The 2-methyl-4-hydroxy-naphthyl group is first removed by horseradish peroxidase. The exposed phosphate group is then removed with alkaline phosphatase. The exposed phenoxy 1,2-dioxetane decomposes to generate chemiluminescence output in immunoassays or nucleic acid hybridization assays.
    Type: Grant
    Filed: May 31, 1989
    Date of Patent: July 21, 1992
    Assignee: Chiron Corporation
    Inventors: Michael S. Urdea, Brian D. Warner
  • Patent number: 5026875
    Abstract: Disclosed is a composition comprising 1,3,5-trioxane, and more particularly a stability-improved trioxane composition.
    Type: Grant
    Filed: April 27, 1989
    Date of Patent: June 25, 1991
    Assignee: Mitsubishi Gas Chemical Company, Inc.
    Inventors: Mutsuhiko Takeda, Minoru Kakuda, Masafumi Shimpo, Kiyoshi Yoshida
  • Patent number: 4692513
    Abstract: Alpha-L-Aspartyl-D-heteroaromatic-substituted glycine esters and amides are disclosed to be useful as high intensity sweeteners. These compounds can be used to sweeten a variety of foods, beverages and other oral products.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: September 8, 1987
    Assignee: The Procter & Gamble Company
    Inventors: Robert B. Blum, John M. Gardlik, John M. Janusz, George P. Rizzi
  • Patent number: 4415476
    Abstract: A catalyst comprises sodium and cesium as a cationic component and chlorine as an anionic component in addition to silver which is a typical conventional catalyst component for the production of ethylene oxide by oxidation of ethylene. Use of the catalyst of the invention gives ethylene oxide at an improved selectivity.
    Type: Grant
    Filed: February 18, 1982
    Date of Patent: November 15, 1983
    Assignee: Mitsubishi Petrochemical Co. Ltd.
    Inventors: Akimi Ayame, Naohiro Nojiri, Yukio Sakai
  • Patent number: 4414135
    Abstract: A catalyst comprising sodium and cesium as a cationic component and at least one of bromine and fluorine as an anionic component in addition to silver which is a typical conventional catalyst component for the production of ethylene oxide by oxidation of ethylene. Use of the catalyst of the invention gives ethylene oxide at an improved selectivity.
    Type: Grant
    Filed: February 18, 1982
    Date of Patent: November 8, 1983
    Assignee: Mitsubishi Petrochemical Co. Ltd.
    Inventors: Naohiro Nojiri, Yukio Sakai
  • Patent number: 4347192
    Abstract: Derivatives of .alpha.,.beta.-unsaturated ketones having anticonvulsant activity and methods of their preparation from heterocyclic phosphonium salts and acyclic phosphoranes are disclosed.
    Type: Grant
    Filed: July 24, 1980
    Date of Patent: August 31, 1982
    Assignee: G. D. Searle & Co.
    Inventor: Richard A. Mueller